Prothena reported -37744000 in EBITDA for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acadia Pharmaceuticals ACAD:US $ -112.5M 68.38M
Agios Pharmaceuticals AGIO:US $ -98.67M 3.96M
Akebia Therapeutics AKBA:US $ -49.06M 7.64M
ALKERMES ALKS:US $ -7.39M 30.91M
Alnylam Pharmaceuticals ALNY:US $ -137.27M 45.91M
Amgen AMGN:US $ 3341M 185M
Biogen BIIB:US $ 674.7M 20.2M
Biomarin Pharmaceutical BMRN:US $ 56.67M 96.56M
Exelixis EXEL:US $ 87.73M 30.84M
Intercept Pharmaceuticals ICPT:US $ -9.9M 10.55M
Intra Cellular Therapies ITCI:US $ -72.49M 13.37M
IONIS PHARMACEUT IONS:US $ -53.21M 278.25M
Macrogenics MGNX:US $ -63725000 8.44M
Nektar Therapeutics NKTR:US $ -111.36M 1.88M
Neurocrine Biosciences NBIX:US $ 6.4M 60.6M
Prothena PRTA:US -37744000 4.89M
Regeneron Pharmaceuticals REGN:US $ 1360.9M 1353.3M
Seattle Genetics SGEN:US $ -115.96M 37.85M
Ultragenyx Pharmaceutical RARE:US $ -132.54M 33.51M
Vertex Pharmaceuticals VRTX:US $ 1069.3M 159.74M
Vital Therapies VTL:US $ -21.41M 0.26M
Xoma XOMA:US $ -2063000 32.43M
YTE INCY:US $ 144.1M 9.29M